Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of opioids on immunomarkers using gene expression profiling
2006-004071-34Phase 3Completed
- Sponsor
- Queen Mary University of London
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing Morphine group, Oxycodone group and Epidural bupivacaine group (3 arms). Primary endpoint: Immune cell changes (CD4, CD8, NK cells). Started Oct 2006; status: completed.
02
Drugs
oxycodonemorphinebupivacaine
Beyond the preview
Go deeper on 2006-004071-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004071-34.